Present state of immunosuppressive therapy in liver transplant recipients (Q37919421)

25 August 2017

1 reference

title

Present state of immunosuppressive therapy in liver transplant recipients (English)

1 reference

25 August 2017

2

John J Fung

1 reference

25 August 2017

Russell H Wiesner

1

1 reference

25 August 2017

publication date

1 November 2011

1 reference

25 August 2017

published in

Liver Transplantation

1 reference

25 August 2017

volume

17 Suppl 3

1 reference

25 August 2017

page(s)

S1-9

1 reference

T-Cell Function and Migration — Two Sides of the Same Coin

25 August 2017

cites work

1 reference

T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.

21 January 2018

1 reference

How antigen quantity and quality determine T-cell decisions in lymphoid tissue

21 January 2018

1 reference

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1

21 January 2018

1 reference

Basic concepts in transplant immunology

21 January 2018

1 reference

Immunosuppressive drugs for kidney transplantation.

21 January 2018

1 reference

Screening of mortality in transplant patients using an assay for immune function.

21 January 2018

1 reference

State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression

21 January 2018

1 reference

Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay

21 January 2018

1 reference

Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.

21 January 2018

1 reference

Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study

21 January 2018

1 reference

Weaning of immunosuppression in liver transplant recipients

21 January 2018

1 reference

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

21 January 2018

1 reference

Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies

21 January 2018

1 reference

Daclizumab induction therapy in liver transplant recipients with renal insufficiency

21 January 2018

1 reference

Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial

21 January 2018

1 reference

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.

21 January 2018

1 reference

Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.

21 January 2018

1 reference

Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database

21 January 2018

1 reference

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report

21 January 2018

1 reference

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

A Decade of Experience Using mTor Inhibitors in Liver Transplantation

21 January 2018

1 reference

Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis

21 January 2018

1 reference

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study

21 January 2018

1 reference

A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.

21 January 2018

1 reference

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study

21 January 2018

1 reference

Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study

21 January 2018

1 reference

Influence of steroids on HCV recurrence after liver transplantation: A prospective study

21 January 2018

1 reference

Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation

21 January 2018

1 reference

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.22410

1 reference

25 August 2017

1 reference